KRAS driver mutations, mostly occurred on 12th or 13th amino acid, which are commonly found in pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC), present as attractive targets for immunotherapy. The gene discussed is KRAS; the disease is colorectal cancer.